Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W Kensler

Showing results (1-10 of 235) with videos related to

Pageof 24
Sort By:
Archives of Pharmacal Research|November 30, 2019
Nrf2 in liver toxicologyKeiko Taguchi, Thomas W Kensler
Carcinogenesis|October 2, 2009
Nrf2: friend or foe for chemoprevention?Thomas W Kensler, Nobunao Wakabayashi
Current Diabetes Reviews|February 1, 2013
New player on an old field; the keap1/Nrf2 pathway as a target for treatment of type 2 diabetes and metabolic syndromeDionysios V Chartoumpekis, Thomas W Kensler
Expert Review of Anticancer Therapy|October 18, 2002
Chemoprotective potential of phase 2 enzyme inducersRyan A Dick, Thomas W Kensler
Current Oncology Reports|October 2, 2002
Prevention of liver cancerKathryn Z Guyton, Thomas W Kensler
Drug News & Perspectives|April 19, 2007
Chemopreventive promise of targeting the Nrf2 pathwayMelinda S Yates, Thomas W Kensler
Toxicology and Applied Pharmacology|September 8, 2009
Targeting NRF2 signaling for cancer chemopreventionMi-Kyoung Kwak, Thomas W Kensler
Frontiers in Nutrition|May 17, 2021
The Challenges of Designing and Implementing Clinical Trials With Broccoli Sprouts… and Turning Evidence Into Public Health ActionJed W Fahey, Thomas W Kensler
Mutation Research|January 1, 2008
Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insultsWilliam O Osburn, Thomas W Kensler
The Journal of Biological Chemistry|February 18, 2004
The catalytic and kinetic mechanisms of NADPH-dependent alkenal/one oxidoreductaseRyan A Dick, Thomas W Kensler
Pageof 24

Showing results (1-10 of 235) with videos related to

Sort By:
Pageof 24
Archives of Pharmacal Research|November 30, 2019
Nrf2 in liver toxicologyKeiko Taguchi, Thomas W Kensler
Carcinogenesis|October 2, 2009
Nrf2: friend or foe for chemoprevention?Thomas W Kensler, Nobunao Wakabayashi
Current Diabetes Reviews|February 1, 2013
New player on an old field; the keap1/Nrf2 pathway as a target for treatment of type 2 diabetes and metabolic syndromeDionysios V Chartoumpekis, Thomas W Kensler
Expert Review of Anticancer Therapy|October 18, 2002
Chemoprotective potential of phase 2 enzyme inducersRyan A Dick, Thomas W Kensler
Current Oncology Reports|October 2, 2002
Prevention of liver cancerKathryn Z Guyton, Thomas W Kensler
Drug News & Perspectives|April 19, 2007
Chemopreventive promise of targeting the Nrf2 pathwayMelinda S Yates, Thomas W Kensler
Toxicology and Applied Pharmacology|September 8, 2009
Targeting NRF2 signaling for cancer chemopreventionMi-Kyoung Kwak, Thomas W Kensler
Frontiers in Nutrition|May 17, 2021
The Challenges of Designing and Implementing Clinical Trials With Broccoli Sprouts… and Turning Evidence Into Public Health ActionJed W Fahey, Thomas W Kensler
Mutation Research|January 1, 2008
Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insultsWilliam O Osburn, Thomas W Kensler
The Journal of Biological Chemistry|February 18, 2004
The catalytic and kinetic mechanisms of NADPH-dependent alkenal/one oxidoreductaseRyan A Dick, Thomas W Kensler
Pageof 24